Clinical trial
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study
NCT02750501
Study timeline
Study start (actual)2016-07-20Date precision: day
Registry last updated2018-08-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cystic Fibrosisunresolved
Interventions
Sponsors & collaborators
Alcresta Therapeutics, Inc.lead sponsor
Cystic Fibrosis Foundationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02750501 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.